School of Pharmacy, Sungkyunkwan University, Suwon, South Korea, Republic of Korea
Disclosure information not submitted.
1A-05 - End-stage renal diseases associated with the use of SGLT2 inhibitors versus GLP-1 receptor agonists among individuals with metabolic dysfunction-associated steatotic liver disease: A nationwide cohort study
Sunday, August 24, 202511:30 AM - 11:45 AM ET
3B-06 - Timing of antidiabetic medication initiation and risk of major adverse cardiovascular events and mortality: A target trial emulation with clone-censor-weight approach
Monday, August 25, 20259:30 AM - 9:45 AM ET
6C-05 - Aspirin use and the risk of hepatic events in patients with metabolic dysfunction-associated steatotic liver disease: A target trial emulation with clone-censor-weight approach
Tuesday, August 26, 20252:30 PM - 2:45 PM ET
6G-05 - Timing of SGLT2 inhibitors Initiation on Clinical Complications in Diabetic Metabolic Dysfunction-Associated Steatotic Liver Disease: A Target Trial Emulation Study With a Clone-Censor-Weight Approach
